Changes in lipid and lipoprotein levels and Achilles tendon diameters and indices in familial hypercholesterolaemic patients with tendinous xanthomatosis treated by diet and bezafibrate for 2 years.
Thirteen young adult patients suffering from heterozygotic familial hypercholesterolaemia with tendinous xanthomatosis, previously treated with a suitable special diet, were studied to assess the effect of bezafibrate, given for 2 years at a dose of 800 mg/day, on plasma lipid and lipoprotein levels and on changes in size of the Achilles tendon xanthomas. Measurements were made before and at intervals during treatment, the tendinous xanthomas being measured by an echographic procedure to give data on antero-posterior and lateral diameters, thus enabling an Achilles tendon index to be defined. The results confirm the hypolipidaemic activity of bezafibrate, changes in the levels of total cholesterol, triglycerides, lipids and lipoproteins (LDL, VLDL and HDL) being similar in direction and magnitude to those reported previously. A significant regression in the size of the Achilles tendon xanthomas was observed in 11 of the 13 patients, and the regression in the Achilles tendon index correlated significantly with a favourable change in the ratio HDL/LDL + VLDL. It is suggested that, as a result of this objective observation, a favourable effect of bezafibrate treatment would possibly be seen on the anatomical atheromatous lesions which are usual in this type of hyperlipidaemia.
Rouffy
J
J
Department of Internal Medicine and Vascular Pathology, Hôpital Saint-Louis, Paris, France.
Chanu
B
B
Bakir
R
R
Goy-Loeper
J
J
Djian
F
F
Monsuez
J J
JJ
Gomberg
R
R
Laval-Jeantet
M
M
D000125:Achilles Tendon / Q000473:pathology; D000328:Adult; D001629:Bezafibrate / Q000627:therapeutic use*; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D014973:Xanthomatosis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology
D002791:Cholesterol, Dietary; D008055:Lipids; D008074:Lipoproteins; D001629:Bezafibrate